Health News : diabetes - News from other sources. | | | | | | | | | | Press Release Tue, 16 Apr, 2013 10:08 AM PDT The Market Publishers Ltd. Posted on:16 Apr 13 Invokana (canagliflozin) belongs within the new class of type 2 diabetes treatments called selective sodium glucose co-transporter 2 (SGLT2) inhibitors. Continue reading | | Coming up Tue, 16 Apr, 2013 09:27 AM PDT Central Ohio Diabetes Association Family Fun Walk & Run, 9 a.m. April 27 at Genoa Park in downtown Columbus Continue reading | | | |
No comments:
Post a Comment